Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia

Abstract Objective To investigate the ZAP-70 and CD38 expressions and their combined expressions in Sudanese B-CLL patients and their relationships with clinical and hematological characteristics as well as the disease staging at presentation. Results In the present cross-sectional descriptive study...

Full description

Bibliographic Details
Main Authors: Ameen Abdulaziz Basabaeen, Enaam Abdelrhman Abdelgader, Othman Saeed BaHashwan, Ebtihal Ahmed Babekir, Nour Mahmoud Abdelateif, Salem Ahmed Bamusa, Saadia Osman Abdelrahim, Osama Ali Altayeb, Eman Abbass Fadul, Ibrahim Khider Ibrahim
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Research Notes
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13104-019-4319-8
_version_ 1819076429705379840
author Ameen Abdulaziz Basabaeen
Enaam Abdelrhman Abdelgader
Othman Saeed BaHashwan
Ebtihal Ahmed Babekir
Nour Mahmoud Abdelateif
Salem Ahmed Bamusa
Saadia Osman Abdelrahim
Osama Ali Altayeb
Eman Abbass Fadul
Ibrahim Khider Ibrahim
author_facet Ameen Abdulaziz Basabaeen
Enaam Abdelrhman Abdelgader
Othman Saeed BaHashwan
Ebtihal Ahmed Babekir
Nour Mahmoud Abdelateif
Salem Ahmed Bamusa
Saadia Osman Abdelrahim
Osama Ali Altayeb
Eman Abbass Fadul
Ibrahim Khider Ibrahim
author_sort Ameen Abdulaziz Basabaeen
collection DOAJ
description Abstract Objective To investigate the ZAP-70 and CD38 expressions and their combined expressions in Sudanese B-CLL patients and their relationships with clinical and hematological characteristics as well as the disease staging at presentation. Results In the present cross-sectional descriptive study, analysis of ZAP-70 expression showed that 36/110 (32.7%) patients positively expressed ZAP-70 and insignificant higher presentation in intermediate and at advanced stages as well as no correlation was seen with hematological parameters and clinical features compared with negatively ZAP-70, on the other hand, 41/110 (37.3%) were CD38+ and no significant correlation was shown with the stage at presentation, clinical characteristics (except Splenomegaly, P = 0.02) and hematological parameters. However, in combined expressions of both ZAP-70 and CD38 together, 20/110 (18.2%) were concordantly ZAP-70+/CD38+, 53/110 (48.2%) concordantly ZAP-70−/CD38− and 37/110 (33.6%) either ZAP-70+ or CD38+, and these three groups showed insignificant correlation with clinical (except Splenomegaly, P = 0.03) and hematological parameters, and the stage at presentation. Our data showed the combined analysis of these two markers, lead to classify our patients into three subgroups (either concordant positive, negative or discordant expressions) with statistically insignificant correlation with clinical presentation (except Splenomegaly), hematological parameters and stage at presentation of B-CLL patients.
first_indexed 2024-12-21T18:41:10Z
format Article
id doaj.art-aecf7a82840548a6b64515d040bb1f5d
institution Directory Open Access Journal
issn 1756-0500
language English
last_indexed 2024-12-21T18:41:10Z
publishDate 2019-05-01
publisher BMC
record_format Article
series BMC Research Notes
spelling doaj.art-aecf7a82840548a6b64515d040bb1f5d2022-12-21T18:54:01ZengBMCBMC Research Notes1756-05002019-05-011211610.1186/s13104-019-4319-8Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemiaAmeen Abdulaziz Basabaeen0Enaam Abdelrhman Abdelgader1Othman Saeed BaHashwan2Ebtihal Ahmed Babekir3Nour Mahmoud Abdelateif4Salem Ahmed Bamusa5Saadia Osman Abdelrahim6Osama Ali Altayeb7Eman Abbass Fadul8Ibrahim Khider Ibrahim9Department of Hematology, Faculty of Medical Laboratory Sciences, Al Neelain UniversityDepartment of Pathology, Faculty of Medicine, Al Neelain UniversityDepartment of Family Medicine, Faculty of Medicine, University of GeziraDepartment of Hematology, Faculty of Medical Laboratory Sciences, Al Neelain UniversityDepartment of Hematology, Faculty of Medical Laboratory Sciences, Al Neelain UniversityMinistry of Health & PopulationDepartment of Hematology, Faculty of Medical Laboratory Sciences, Al Neelain UniversityFlow Cytometry Laboratory for Leukemia & Lymphoma DiagnosisFlow Cytometry Laboratory for Leukemia & Lymphoma DiagnosisDepartment of Hematology, Faculty of Medical Laboratory Sciences, Al Neelain UniversityAbstract Objective To investigate the ZAP-70 and CD38 expressions and their combined expressions in Sudanese B-CLL patients and their relationships with clinical and hematological characteristics as well as the disease staging at presentation. Results In the present cross-sectional descriptive study, analysis of ZAP-70 expression showed that 36/110 (32.7%) patients positively expressed ZAP-70 and insignificant higher presentation in intermediate and at advanced stages as well as no correlation was seen with hematological parameters and clinical features compared with negatively ZAP-70, on the other hand, 41/110 (37.3%) were CD38+ and no significant correlation was shown with the stage at presentation, clinical characteristics (except Splenomegaly, P = 0.02) and hematological parameters. However, in combined expressions of both ZAP-70 and CD38 together, 20/110 (18.2%) were concordantly ZAP-70+/CD38+, 53/110 (48.2%) concordantly ZAP-70−/CD38− and 37/110 (33.6%) either ZAP-70+ or CD38+, and these three groups showed insignificant correlation with clinical (except Splenomegaly, P = 0.03) and hematological parameters, and the stage at presentation. Our data showed the combined analysis of these two markers, lead to classify our patients into three subgroups (either concordant positive, negative or discordant expressions) with statistically insignificant correlation with clinical presentation (except Splenomegaly), hematological parameters and stage at presentation of B-CLL patients.http://link.springer.com/article/10.1186/s13104-019-4319-8B-CLLZAP-70CD38CombinedRaiBinet
spellingShingle Ameen Abdulaziz Basabaeen
Enaam Abdelrhman Abdelgader
Othman Saeed BaHashwan
Ebtihal Ahmed Babekir
Nour Mahmoud Abdelateif
Salem Ahmed Bamusa
Saadia Osman Abdelrahim
Osama Ali Altayeb
Eman Abbass Fadul
Ibrahim Khider Ibrahim
Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia
BMC Research Notes
B-CLL
ZAP-70
CD38
Combined
Rai
Binet
title Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia
title_full Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia
title_fullStr Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia
title_full_unstemmed Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia
title_short Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia
title_sort combined analysis of zap 70 and cd38 expression in sudanese patients with b cell chronic lymphocytic leukemia
topic B-CLL
ZAP-70
CD38
Combined
Rai
Binet
url http://link.springer.com/article/10.1186/s13104-019-4319-8
work_keys_str_mv AT ameenabdulazizbasabaeen combinedanalysisofzap70andcd38expressioninsudanesepatientswithbcellchroniclymphocyticleukemia
AT enaamabdelrhmanabdelgader combinedanalysisofzap70andcd38expressioninsudanesepatientswithbcellchroniclymphocyticleukemia
AT othmansaeedbahashwan combinedanalysisofzap70andcd38expressioninsudanesepatientswithbcellchroniclymphocyticleukemia
AT ebtihalahmedbabekir combinedanalysisofzap70andcd38expressioninsudanesepatientswithbcellchroniclymphocyticleukemia
AT nourmahmoudabdelateif combinedanalysisofzap70andcd38expressioninsudanesepatientswithbcellchroniclymphocyticleukemia
AT salemahmedbamusa combinedanalysisofzap70andcd38expressioninsudanesepatientswithbcellchroniclymphocyticleukemia
AT saadiaosmanabdelrahim combinedanalysisofzap70andcd38expressioninsudanesepatientswithbcellchroniclymphocyticleukemia
AT osamaalialtayeb combinedanalysisofzap70andcd38expressioninsudanesepatientswithbcellchroniclymphocyticleukemia
AT emanabbassfadul combinedanalysisofzap70andcd38expressioninsudanesepatientswithbcellchroniclymphocyticleukemia
AT ibrahimkhideribrahim combinedanalysisofzap70andcd38expressioninsudanesepatientswithbcellchroniclymphocyticleukemia